Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes

NCT01697631 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 30
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S